Retraction notice to "A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design" [Mech. Ageing Dev. 213 (2023) 111825].

Mech Ageing Dev

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel; Icahn School of Medicine at Mount Sinai, Department of Psychiatry, New York, NY 10029, USA.

Published: June 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.mad.2024.111937	DOI Listing

Publication Analysis

retraction notice

notice feasibility

feasibility study

study combination

combination intranasal

intranasal insulin

insulin dulaglutide

dulaglutide cognition

cognition older

older adults

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!